Rashi Kalra

Rashi Kalra

Baylor College of Medicine

H-index: 9

North America-United States

About Rashi Kalra

Rashi Kalra, With an exceptional h-index of 9 and a recent h-index of 9 (since 2020), a distinguished researcher at Baylor College of Medicine, specializes in the field of Cancer biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma

Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy

The uncharted role of HER2 mutant alleles in breast cancer

Poziotinib inhibits HER2-mutant–driven therapeutic resistance and multiorgan metastasis in breast cancer

Nuclear receptor Nr1d1 alleviates asthma by abating GATA3 gene expression and Th2 cell differentiation

Abstract P2-13-24: Distinct HER2 allele specific therapeutic response and preclinical efficacy of poziotinib in metastatic ER+ HER2 mutant breast cancer

Vitamin D3-VDR-PTPN6 axis mediated autophagy contributes to the inhibition of macrophage foam cell formation

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

Rashi Kalra Information

University

Position

Postdoctoral Associate

Citations(all)

282

Citations(since 2020)

240

Cited By

123

hIndex(all)

9

hIndex(since 2020)

9

i10Index(all)

9

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Rashi Kalra Skills & Research Interests

Cancer biology

Top articles of Rashi Kalra

Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma

Blood, The Journal of the American Society of Hematology

2021/5/27

Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy

2023/1/2

The uncharted role of HER2 mutant alleles in breast cancer

Oncotarget

2023

Rashi Kalra
Rashi Kalra

H-Index: 7

Bora Lim
Bora Lim

H-Index: 22

Poziotinib inhibits HER2-mutant–driven therapeutic resistance and multiorgan metastasis in breast cancer

Cancer Research

2022/8/16

Nuclear receptor Nr1d1 alleviates asthma by abating GATA3 gene expression and Th2 cell differentiation

Cellular and Molecular Life Sciences

2022/6

Abstract P2-13-24: Distinct HER2 allele specific therapeutic response and preclinical efficacy of poziotinib in metastatic ER+ HER2 mutant breast cancer

Cancer Research

2022/2/15

Vitamin D3-VDR-PTPN6 axis mediated autophagy contributes to the inhibition of macrophage foam cell formation

Autophagy

2021/9/2

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

Nature communications

2021/5/19

Rashi Kalra
Rashi Kalra

H-Index: 7

Ching Hui Chen
Ching Hui Chen

H-Index: 2

Abstract PD8-05: Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

Cancer Research

2021/2/15

See List of Professors in Rashi Kalra University(Baylor College of Medicine)